| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 07/14/2011 | US20110173717 BPMV-based viral constructs useful for VIGS and expression of heterologous proteins in legumes |
| 07/14/2011 | US20110173716 EPSP synthase with high glyphosate resistance and its encoded sequence |
| 07/14/2011 | US20110173715 Nucleic acid sequences encoding proteins associated with abiotic stress response and plant cells and plants with increased tolerance to environmental stress |
| 07/14/2011 | US20110173714 Msca1 nucleotide sequences impacting plant male fertility and method of using same |
| 07/14/2011 | US20110173713 Methods and compositions to select cotton plants resistant to cotton root knot nematode |
| 07/14/2011 | US20110173712 Enhancement of plant yield vigor and stress tolerance |
| 07/14/2011 | US20110173711 eNos Mutations Useful for Gene Therapy and Therapeutic Screening |
| 07/14/2011 | US20110173710 Chimeric meganuclease enzymes and uses thereof |
| 07/14/2011 | US20110172975 Generation and reproduction of dna sequences and analysis of polymorphisms and mutations by using error-correcting codes |
| 07/14/2011 | US20110172407 Phenotypic and genotypic differences of mva strains |
| 07/14/2011 | US20110172406 Molecular structure of rhd negative |
| 07/14/2011 | US20110172405 Method for small rna isolation |
| 07/14/2011 | US20110172404 Self-Assembly of Nanoparticles Through Nuclei Acid Engineering |
| 07/14/2011 | US20110172403 Microfluidic Device Including Purification Column with Excess Diluent and Method |
| 07/14/2011 | US20110172398 Bispecific binding molecules for anti-angiogenesis therapy |
| 07/14/2011 | US20110172296 Modulation of transforming growth factor-beta 1 expression |
| 07/14/2011 | US20110172295 METHODS AND COMPOSITIONS FOR THE REGULATION OF microRNA PROCESSING |
| 07/14/2011 | US20110172294 Cyclohexenyl nucleic acids analogs |
| 07/14/2011 | US20110172293 Methods and Compositions for Modulating Angiogenesis |
| 07/14/2011 | US20110172291 Rna interference for the treatment of gain-of-function disorders |
| 07/14/2011 | US20110172290 Isoforms of eIF-5A: Senescence-induced eIF5A; Wounding-induced elF-5A; Growth elF-5A; and DHS |
| 07/14/2011 | US20110172289 Minor groove binder (mgb)-oligonucleotide mirna antagonists |
| 07/14/2011 | US20110172288 Compositions and Methods for the Identification, Assessment, Prevention and Therapy of Thymic Lymphoma or Hamartomatous Tumours |
| 07/14/2011 | US20110172286 Cd44 splice variants in neurodegenerative diseases |
| 07/14/2011 | US20110172170 Interferon-like protein zcyto21 |
| 07/14/2011 | US20110172168 Ilt-2 (lir1) variants with increased affinity for mhc class i molecules |
| 07/14/2011 | US20110172165 Modified linkers |
| 07/14/2011 | US20110172153 Screening methods using g-protein coupled receptors and related compositions |
| 07/14/2011 | US20110172148 Periostin-induced pancreatic regeneration |
| 07/14/2011 | US20110172146 Growth hormone polypeptides and methods of making and using same |
| 07/14/2011 | US20110172144 Methods for increasing expression of serca2a in cardiac muscle |
| 07/14/2011 | US20110172139 Peptides whose uptake by cells is controllable |
| 07/14/2011 | US20110172115 Characterising planar samples by mass spectrometry |
| 07/14/2011 | US20110172113 Aberrant mitochondrial dna, associated fusion transcripts and hybridization probes therefor |
| 07/14/2011 | US20110172105 GREPSEQ: An Almost Inexhaustible, Cost-Effective, High-Throughput Protocol for the Generation of Selector Sequences |
| 07/14/2011 | US20110171749 Nanoparticle tracer-based electrochemical dna sensor for detection of pathogens-amplification by a universal nano-tracer (aunt) |
| 07/14/2011 | US20110171740 Bioassays based on polymeric sequence probe |
| 07/14/2011 | US20110171737 Protein engineering |
| 07/14/2011 | US20110171728 Method and composition for crystallizing G protein-coupled receptors |
| 07/14/2011 | US20110171718 Proteases With Modified Pre-Pro Regions |
| 07/14/2011 | US20110171716 Carbohydrate-based drug delivery polymers and conjugates thereof |
| 07/14/2011 | US20110171699 Preparation of 6-aminocaproic acid from 5 -formyl valeri c acid |
| 07/14/2011 | US20110171698 C-22 hydroxylase |
| 07/14/2011 | US20110171694 Alpha-Amylase Mutants with Altered Properties |
| 07/14/2011 | US20110171693 Amylases, nucleic acids encoding them and methods for making and using them |
| 07/14/2011 | US20110171686 Reverse cumate repressor mutant |
| 07/14/2011 | US20110171678 Modified carbocyanine dyes and their conjugates |
| 07/14/2011 | US20110171675 Fret-based membrane-type 1 matrix metalloproteinase biosensor and methods for using the same |
| 07/14/2011 | US20110171674 Beta-Glucosidase Variants Having Improved Activity, and Uses Thereof |
| 07/14/2011 | US20110171669 Isolated luciferase gene of L. ITALICA |
| 07/14/2011 | US20110171654 Allelic ladder loci |
| 07/14/2011 | US20110171653 Method for detecting cryptosporidium |
| 07/14/2011 | US20110171648 Method of detecting and quantifying hepatitis c virus |
| 07/14/2011 | US20110171644 Multiplex capture of nucleic acids |
| 07/14/2011 | US20110171643 Method, process, and kit for cancer diagnosis, prognosis, and aftercare |
| 07/14/2011 | US20110171640 Method for isolating cell free apoptotic or fetal nucleic acids |
| 07/14/2011 | US20110171639 Polymer for detection of target substance, and method for detection of target substance |
| 07/14/2011 | US20110171637 Methods and nucleic acids for analyses of cellular proliferative disorders |
| 07/14/2011 | US20110171635 Nucleic acid enzyme biosensors for ions |
| 07/14/2011 | US20110171632 Loss of heterozygosity of the dna markers in the 12q22-23 region |
| 07/14/2011 | US20110171627 Zcytor19 heterodimeric cytokine receptor polynucleotides, polypeptides, antibodies and methods |
| 07/14/2011 | US20110171315 Oral recombinant helicobacter pylori vaccine and preparing method thereof |
| 07/14/2011 | US20110171287 Use of Oligonucleotides with Modified Bases as Antiviral Agents |
| 07/14/2011 | US20110171285 Design of Fibrinogen and Fibrinogen Derived Products with Reduced Bacterial Binding by Using Modified Sequences of Fibrinogen Chains |
| 07/14/2011 | US20110171263 Compositions and methods of use of orf-1358 from beta-hemolytic streptococcal strains |
| 07/14/2011 | US20110171253 Novel astrovirus |
| 07/14/2011 | US20110171252 Streptococcus suis vaccines and diagnostic tests |
| 07/14/2011 | US20110171251 Piscirickettsia salmonis antigens and use thereof |
| 07/14/2011 | US20110171250 Synthetic Gene Construct Coding for an HIV1 GAG and Use Thereof for Obtaining Anti-HIV-1 Vaccines |
| 07/14/2011 | US20110171249 Chimeric chikungunya virus and uses thereof |
| 07/14/2011 | US20110171244 Recombinant protein carrying human papillomavirus epitopes inserted in an adenylate cyclase protein or fragment thereof therapeutic uses thereof |
| 07/14/2011 | US20110171233 Antibodies Against Human Cytomegalovirus (HCMV) |
| 07/14/2011 | US20110171231 ANTI-PlGF ANTIBODIES AND METHODS USING SAME |
| 07/14/2011 | US20110171230 Method of Identifying Agents that Promote Axonal Development |
| 07/14/2011 | US20110171226 Novel Subtype of Closteridium Botulinum Neurotoxin Type A and Uses Thereof |
| 07/14/2011 | US20110171225 Novel Plasmodium Falciparum Gene Encoding Signal Peptide Peptidase and Method of Using Inhibitors Thereof for Inhibiting Malarial Infection |
| 07/14/2011 | US20110171222 Anti-her3 antibodies and uses thereof |
| 07/14/2011 | US20110171221 Compositions and methods for the treatment of a neoplasia |
| 07/14/2011 | US20110171218 Compositions and methods for increasing serum half-life |
| 07/14/2011 | US20110171216 Monoclonal antibodies specific for pancreatic neoplasia cells |
| 07/14/2011 | US20110171215 Pd-1 specific antibodies and uses thereof |
| 07/14/2011 | US20110171210 Humanized monoclonal antibodies and methods of use |
| 07/14/2011 | US20110171205 Novel 15571, 2465, 14266, 2882, 52871, 8203 and 16852 molecules and uses therefor |
| 07/14/2011 | US20110171204 Antibodies to ntb-a |
| 07/14/2011 | US20110171191 Suppression of neuroendocrine diseases |
| 07/14/2011 | US20110171176 Complement antagonists and uses thereof |
| 07/14/2011 | US20110171173 Ifn-alpha/beta-independent mechanism of antiviral protection through a novel ligand-receptor pair: ifn- ligands engage a novel receptor ifn-rn (crf2-12) and il-10r2 (crf2-4) for signaling andinduction of biological activities |
| 07/14/2011 | US20110171170 Cytotoxic t cell defined egfr peptide and an optimized derivative peptide |
| 07/14/2011 | US20110171127 Nucleic acid and corresponding protein entitled 162p1e6 useful in treatment and detection of cancer |
| 07/14/2011 | US20110170075 Device for chemical and biochemical reactions using photo-generated reagents |
| 07/14/2011 | CA2786071A1 Modulation of angiopoietin-like 3 expression |
| 07/13/2011 | EP2343367A1 Mutated Abl kinase domains |
| 07/13/2011 | EP2343366A1 Mutated Abl kinase domains |
| 07/13/2011 | EP2343365A1 Mutated Abl kinase domains |
| 07/13/2011 | EP2343364A2 Tubulin regulatory elements for use in plants |
| 07/13/2011 | EP2343307A1 Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response |
| 07/13/2011 | EP2343084A1 Functional influenza virus-like particles (VLP) |
| 07/13/2011 | EP2342339A2 Screening methods for identifying specific staphylococcus aureus inhibitors |
| 07/13/2011 | EP2342224A2 Novel vectors for production of interferon |
| 07/13/2011 | EP2341943A2 Compositions and methods for the specific inhibition of gene expression by dsrna possessing modifications |